Last Updated: August 3, 2026

Suppliers and packagers for TECHNESCAN PYP KIT


✉ Email this page to a colleague

« Back to Dashboard


TECHNESCAN PYP KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Curium TECHNESCAN PYP KIT technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017538 NDA Curium US LLC 69945-094-20 5 VIAL in 1 CELLO PACK (69945-094-20) / 10 mL in 1 VIAL (69945-094-01) 2015-10-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TECHNESCAN PYP KIT

Last updated: July 2, 2026

TECHNESCAN PYP KIT Suppliers: Who Manufactures, Distributes, and Supplies Tc-99m Pyrophosphate in the US?

Executive summary: TECHNESCAN PYP KIT (technetium Tc 99m pyrophosphate) is supplied in the US as a radiopharmaceutical kit through authorized radiopharmacy and nuclear medicine distribution channels. The practical “supplier” set for customers is determined by (1) the kit manufacturer and (2) the US distributor/wholesaler network that delivers the kit to licensed radiopharmacies. No complete, authoritative supplier list (manufacturer + US distributors + known alternative kit sources) can be produced from the information provided.

What companies supply TECHNESCAN PYP KIT to nuclear pharmacies?

Direct answer (featured snippet): Supplier coverage for TECHNESCAN PYP KIT is limited to the manufacturer and its authorized distribution network for radiopharmaceutical kits, with fulfillment typically routed to licensed nuclear medicine providers and radiopharmacies.

Kit supply chain roles

  • Manufacturer of the kit: produces technetium Tc 99m pyrophosphate kit components under the approved manufacturing process.
  • Authorized distributor/wholesaler: ships the kit to licensed radiopharmacies and hospitals.
  • Customer-facing supplier: often the radiopharmacy procurement entity or wholesaler listed on purchase documents, not the end-site manufacturer.

Who manufactures technetium Tc 99m pyrophosphate “kit” products like TECHNESCAN PYP?

Direct answer (featured snippet): TECHNESCAN PYP KIT is a branded radiopharmaceutical kit format. Manufacturing is done by the labeled kit sponsor/manufacturer on the product labeling and regulatory filings; third parties typically do not manufacture the kit under the same brand unless they are licensed/authorized.

Common producer pattern for Tc-99m radiopharmaceutical kits

Tc-99m pyrophosphate kits typically follow a model where:

  • One labeled sponsor manufactures and controls the kit.
  • Another entity supplies generator-eluted Tc-99m for kit reconstitution at the radiopharmacy.
  • Distribution is managed via authorized channels.

What is the Orange Book status of TECHNESCAN PYP KIT, and does it affect supplier availability?

Direct answer (featured snippet): TECHNESCAN PYP KIT is a radiopharmaceutical kit. Orange Book listing is not used to map kit suppliers the way it does for standard small-molecule drugs, and radiopharmaceutical availability is driven more by NDA/BLA labeling and authorized distribution than by generic competition in the Orange Book.

Why supplier lists differ for radiopharmaceuticals

  • Radiopharmaceutical “generic” competition is constrained by kit manufacturing, QC release, and distribution to licensed sites.
  • Reconstitution uses Tc-99m obtained from generators, which adds an operational supply layer beyond the kit itself.

When does TECHNESCAN PYP KIT exclusivity or regulatory change alter suppliers?

Direct answer (featured snippet): Supplier changes generally track changes in the labeled NDA sponsor, authorized distribution agreements, and manufacturing site status, rather than a simple exclusivity cliff.

Regulatory drivers that can change who supplies

  • New manufacturing site approvals
  • Sponsor label transfers
  • Distributor network changes
  • Temporary shortages due to radiopharmaceutical manufacturing constraints

How many alternative suppliers exist for TECHNESCAN PYP KIT substitutes?

Direct answer (featured snippet): Alternative suppliers depend on whether other branded or authorized equivalent Tc-99m pyrophosphate kits exist with comparable labeling for the intended diagnostic use.

Substitute categories

  • Same active ingredient: technetium Tc 99m pyrophosphate kit equivalents
  • Same diagnostic target but different radiotracer: functional alternatives, not true kit substitutes

Which distributors or wholesalers carry TECHNESCAN PYP KIT?

Direct answer (featured snippet): Distributors are identified by the product’s authorized distribution chain and by listings on wholesaler catalogs and radiopharmacy procurement channels. A definitive distributor list requires product-specific labeling and regulatory/wholesaler data.

What typically shows up on purchase orders

  • The wholesaler name on the invoice
  • The procurement platform or radiopharmacy supply contract
  • The receiving licensure entity and delivery state

What patent estate covers TECHNESCAN PYP KIT supply, and does it block generic kits?

Direct answer (featured snippet): Patent barriers can affect kit manufacturing and distribution only where claims cover the kit composition, manufacturing method, or approved clinical use, but supplier availability for radiopharmaceutical kits is also governed by regulatory approval, CGMP control, and authorized distribution.

Patent relevance to suppliers

  • Composition-of-matter and formulation claims can delay entry for direct kit equivalents
  • Method-of-manufacture claims can constrain scale or site transfers
  • Method-of-use claims can constrain labeling-defined substitution

What generic entry risks exist for Tc-99m pyrophosphate kits like TECHNESCAN PYP?

Direct answer (featured snippet): Generic entry risks are driven by the ability to obtain regulatory approval for a kit that matches approved specifications and holds supply reliability under radiopharmaceutical GMP.

Key risk channels

  • Analytical comparability and release specs
  • Manufacturing and sterility/quality control integration
  • Tc-99m generator logistics and reconstitution workflow constraints

How does TECHNESCAN PYP KIT compare with other Tc-99m bone imaging kits for supplier coverage?

Direct answer (featured snippet): Supplier coverage varies by kit sponsor and approved labeling for the intended diagnostic use. Even when active ingredients are different, many radiopharmacies treat supplier procurement as interchangeable by workflow, not by chemical sameness.

Procurement reality at radiopharmacies

  • Radiopharmacies maintain multi-supplier options to mitigate short-term outages
  • Contracting often favors wholesalers with reliable cold-chain and same-day delivery capabilities

Key Takeaways

  • TECHNESCAN PYP KIT supply in practice is defined by the kit manufacturer and its authorized radiopharmaceutical distribution network that serves licensed nuclear medicine providers and radiopharmacies.
  • A complete, accurate supplier list (manufacturer + specific distributors/wholesalers) cannot be produced from the provided prompt alone.
  • Radiopharmaceutical supply dynamics are shaped by regulatory labeling, manufacturing release capability, Tc-99m generator logistics, and distribution authorization.

FAQs

  1. Who can legally purchase TECHNESCAN PYP KIT in the US?
  2. Do radiopharmacies reconstitute TECHNESCAN PYP KIT with any Tc-99m generator, or only specific generators?
  3. Are there equivalent technetium Tc 99m pyrophosphate kits from other sponsors with interchangeable labeling?
  4. How do radiopharmacy distributors manage shortages of Tc-99m kits and generators?
  5. What documentation do suppliers require for TECHNESCAN PYP KIT delivery to hospitals?

References

  1. No citable sources were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.